The neuroprotective effects of micronized PEA (PEA-m) formulation on diabetic peripheral neuropathy in mice

Medicine and Dentistry

• Palmitoylethanolamide 100%
• Diabetic Neuropathy 41%
• Neuroprotective Agent 33%
• Neuroinflammation 25%
• Antagonist 16%
• Pain 16%
• Streptozocin 16%
• Injection 16%
• Anti-Inflammatory Drug 16%
• Nitrosative Stress 8%
• Combination Therapy 8%
• Morbidity 8%
• Sensation 8%
• Deterioration 8%
• Programmed Cell Death 8%
• Angiogenesis 8%
• Oxidative Stress 8%
• Anodyne 8%
• Urine 8%
• Neuropathy 8%
• Injury 8%
• Complication of Diabetes 8%
• Cytokine Release 8%
• Cell Activation 8%
• Sciatic Nerve 8%
• Mortality 8%
• Feeding 8%
• Microglia 8%
• Peroxisome Proliferator Activated Receptor 8%
• Nuclear Factor 8%
• Thermal Hyperalgesia 8%
• Nerve Growth Factor 8%
• Mast Cell 8%
• p38 Mitogen-Activated Protein Kinase 8%
• Clebopride 8%
• Motivation 8%
• Medication 8%
• Mechanism of Action 8%
• Blood 8%
• Peripheral Nerve 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Palmitoylethanolamide 100%
• Diabetic Neuropathy 41%
• Neuroprotective Agent 33%
• Nervous System Inflammation 25%
• Pain 16%
• Animal 16%
• Mouse 16%
• Streptozotocin 16%
• Analgesic Agent 8%
• Deterioration 8%
• Morbidity 8%
• Nuclear Factor 8%
• Peroxisome Proliferator Activated Receptor 8%
• Neuropathy 8%
• Mouse Model 8%
• Nerve Growth Factor 8%
• Clebopride 8%
• Injury 8%
• Mortality 8%
• Diabetogenesis 8%

Neuroscience

• Peripheral Neuropathy 41%
• Neuroprotective Agent 33%
• Diabetes 16%
• Nerve Tissue 16%
• Spinal Cord 16%
• Streptozotocin 16%
• Cell Activation 8%
• Nitrosative Stress 8%
• Apoptosis 8%
• Angiogenesis 8%
• Peripheral Nerve 8%
• Nerve Growth Factor 8%
• Oxidative Stress 8%
• Sciatic Nerve 8%
• Anti-Inflammatory 8%
• Microglia 8%
• Nuclear Factor 8%
• Peroxisome Proliferator-Activated Receptor 8%
• Hyperalgesia 8%
• Mast Cell 8%
• Peripheral Neuropathy 8%